Share >  
Share
Share on Tumblr

Sarabjit Kour Nangra

News »

   latest by relevance
RBI's rupee move won't impact pharma companies, say experts
May 10, 2012 at 14:56 | Source: CNBC-TV18
Chirag Talati, pharma analyst, Espirito Santo Securities says the RBI's move to boost the Indian currency by asking exporters to convert 50% of their foreign exchange holdings into rupees will not have a significant impact on pharma companies.
नतीजों के बाद फार्मा शेयरों में क्या करें
Feb 08, 2012 at 13:54 | Source:
सबरजीत गौर का कहना है कि अभी तक फार्मा कंपनियों के नतीजे उम्मीद के मुताबिक ही रहे हैं।
Post Q1, which stocks hit & missed in the pharma sector
Aug 03, 2011 at 15:59 | Source: CNBC-TV18
In an interview on CNBC-TV18, Sarabjit Kour Nangra, VP - Research, Angel Broking Ltd and Manoj Garg, Institutional Equities - Research, Edelweiss Securities give a detailed view on how to play select stocks in the pharma sector.
Buy Cadila Healthcare on dips: Angel Broking
Aug 03, 2011 at 14:22 | Source: CNBC-TV18
Buy Cadila Healthcare on dips, says Sarabjit Kour Nangra, VP - Research, Angel Broking.
Angel Broking neutral on Sun Pharma
Aug 03, 2011 at 14:01 | Source: CNBC-TV18
Sarabjit Kour Nangra, VP - Research, Angel Broking is neutral on Sun Pharma.
एंजेल ब्रोकिंग के पसंदीदा फार्मा शेयर
Jul 13, 2011 at 13:32 | Source:
सरबजीत कौर के मुताबिक लार्जकैप फार्मा में डॉ रेड्डीज और ल्युपिन आकर्षक निवेश लग रहें है।

Videos »
RBI's rupee move won't impact pharma companies, say experts
Post Q1, which stocks hit & missed in the pharma sector
Buy Cadila Healthcare on dips: Angel Broking
Angel Broking neutral on Sun Pharma
Which sectors will hog limelight on back of Q2 earnings?
more »

Photos »

  /  
Interact & exchange stock tips & market info »

Web Messenger

Platinum Member

107841 Followers

Orchid Chemical  

A day after a fire accident at Orchid Chemicals and Pharmaceuticals` r...

12.07 PM Sep 27th 2011

Web Messenger

Platinum Member

107841 Followers

ICICI Bank  

Buy ICICI Bank with a target of Rs 1324, says Sarabjit Kour

2.03 PM Sep 19th 2011

m.f.whosane

Platinum Member

183 Followers

Piramal Holding  

it is the best course of action in the circumstances. Says Sarabji...

8.38 PM Sep 17th 2011

Related News »
RBI's rupee move won't impact pharma companies, say experts
Sarabjit Kour Nangra, pharma analyst, Angel Broking too agrees with him saying she doesn’t see this move impacting them in terms of their numbers going forward. Below is an edited transcript of their interview on CNBC-TV18. Watch the ...
May 10, 2012 at 08:57 | Source: MoneyControl.com
For drugmakers, prices falling in the US
Sarabjit Kour Nangra, vice president of research at Angel Broking, said though the number of players in niche segments is relatively limited, there has been erosion of prices. Success depends on the marketing and distribution networks a company has in the US market.
May 25, 2012 at 03:25 | Source: Daily News and Analysis

Follow moneycontrol.com

Facebook Twitter Google Plus RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window